Deal count is down, but Arizona’s VC investment surges in second quarter / Phoenix Business Journal
The latest quarterly Venture Monitor report revealed Arizona companies hauled in $463 million during the latest quarter, up from $201 million a year earlier and $228 million in the first quarter, even though the number of deals declined.
A number of biotech and biomedical industries which have picked Tucson as their home base along with University of Arizona research, the BIO5 Institute, venture capital, and university startups have helped to make the biosciences a strong sector in southern Arizona.
Bay Area medical software firm moves to Phoenix, gets major new investment / Phoenix Business Journal (AZ Inno)
Title21 Health Solutions, a software provider for cell and gene therapy labs which relocated to Phoenix earlier this year, is gaining a new majority owner in a French-based private health care specialist.
TGen, which performs COVID-19 sequencing for the state, reports nearly three-quarters of recent cases in Arizona have been caused by the omicron BA.5 sub-variant—thought to be the most infectious strain of the virus yet. Read more: Omicron subvariant B.A. 5 quickly becoming the dominant strain in Arizona
Updated guidance from the Centers for Disease Control and Prevention says most Arizonans should be wearing face masks indoors again based on the COVID-19 hospital bed use, COVID-19 hospital admissions and case rates for the virus.
UA scientists design screening tool for ovarian cancer / Arizona PBS
Jennifer Barton, director of the University of Arizona’s BIO5 Institute in Tucson, talks about a screening tool for ovarian cancer being studied that could help with detecting the disease earlier.